Biomarker changes during acute heart failure treatment
Congestive Heart Failure, 05/04/2012Boyer B et al.
In this preliminary study, patients with ADHF had measurable changes in MR–proANP, MR–proADM, and CT–pro–ET–1 24 hours after initial therapy. A study of association with clinical course and outcomes to determine the role of these markers in risk–stratification is warranted.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.